Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to determine the efficacy of a quadratus lumborum (QL) block in decreasing postoperative pain in patients undergoing myomectomy for uterine fibroids. A QL block is a temporary anesthetic injection in the quadratus lumborum muscle, a muscle in the lower back, that has been previously shown to significantly reduce postoperative pain levels in patients undergoing abdominal and pelvic surgery. Because of its demonstrated effects, the QL block is becoming a standard of anesthesia and surgical care. Since participants will be undergoing a myomectomy procedure, the investigators believe that participants may qualify to participate in this study. The investigators will be comparing patients who receive the QL block (in addition to standard anesthesia and postoperative pain care) with patients who do not receive the QL block (in addition to standard care). The participants will be randomly assigned to one of the two groups and may or may not actually receive the block.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| QL Block with Bupivacaine | Experimental | Participants will get a QL block using 30cc Bupivacaine bilaterally in quadratus lumborum muscle (60cc total). |
|
| Control | Sham Comparator | Participants will get a sham injection of 30cc saline bilaterally in quadratus lumborum muscle (60cc total). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Bupivacain | Drug | 30cc IM injection in each quadratus lumborum muscle (60cc total). |
|
| Measure | Description | Time Frame |
|---|---|---|
| Time in minutes from first analgesic request as measured by medical chart review | Up to 24 hours | |
| Total number of doses of rescue analgesics given as measured by medical chart review | Up to 24 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Pain as measured by visual analog scale (VAS) | VAS is a pain scale from 0-10 with 0 being no pain and 10 being the worst pain ever. | Up to 48 hours after discharge from hospital. |
| Patient satisfaction with perioperative pain management measured on a scale of 1-10 |
| Measure | Description | Time Frame |
|---|---|---|
| Pain as measured by Richmond Agitation Sedation Scale (RASS) | RASS is measured from -5 to +4 with -5 being no response to voice or physical stimulation and +4 being overtly combative, violent, immediate danger to staff | Up to 24 hours |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Catherine P Haering, BA | Contact | 3392011531 | cph43@case.edu |
| Name | Affiliation | Role |
|---|---|---|
| Joseph Findley, MD | University Hospitals | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospitals Ahuja Medical Center | Recruiting | Beachwood | Ohio | 44122 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010149 | Pain, Postoperative |
| D007889 | Leiomyoma |
| ID | Term |
|---|---|
| D011183 | Postoperative Complications |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010146 | Pain |
Not provided
Not provided
| ID | Term |
|---|---|
| D002045 | Bupivacaine |
| D012965 | Sodium Chloride |
| ID | Term |
|---|---|
| D000813 | Anilides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D000814 | Aniline Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Saline | Drug | 30cc IM injection in each quadratus lumborum muscle (60cc total). |
|
Pain management scale with 1 being very disappointed in pain management with 10 being highly satisfied with pain managment. |
| Up to 48 hours after discharge from hospital. |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D009379 | Neoplasms, Muscle Tissue |
| D018204 | Neoplasms, Connective and Soft Tissue |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D000588 |
| Amines |
| D002712 | Chlorides |
| D006851 | Hydrochloric Acid |
| D017606 | Chlorine Compounds |
| D007287 | Inorganic Chemicals |
| D017670 | Sodium Compounds |